Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts
Cells · 2025
DOI: 10.3390/cells14171321 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Eleonora Cattin und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, University of Modena and Reggio Emilia, 41121 Modena, Italy. Hauptthemen laut MEDLINE: Muscular Dystrophy, Emery-Dreifuss, Fibroblasts, Gene Editing, CRISPR-Cas Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'università e della ricerca, Associazione Italiana DIstrofia Muscolare di Emery-Dreifuss - AIDMED, Associazione Alessandra Proietti OdV.
Abstract (Originalsprache)
Emery–Dreifuss muscular dystrophy (EDMD) is caused by mutations in EMD, LMNA, SYNE1, SYNE2, and other related genes. The disease is characterized by joint contractures, muscle weakening and wasting, and heart conduction defects associated with dilated cardiomyopathy. Previous studies demonstrated the activation of fibrogenic molecules such as TGFbeta 2 and CTGF in preclinical models of EDMD2 and increased secretion of TGFbeta 2 in patient serum. A wide screening of patient cells suggested fibrosis, metabolism, and myogenic signaling as the most affected pathways in various EDMD forms. In this study, we show that alpha-smooth muscle actin-positive myofibroblasts are overrepresented in patient fibroblast cultures carrying EMD, LMNA, or SYNE2 mutations, and profibrotic miRNA-21 is upregulated. Upon CRISPR/Cas correction of the mutated EMD or LMNA sequence in EDMD1 or EDMD2 fibroblasts, respectively, we observe a reduced expression of fibrogenic molecules. However, in patient myoblasts, neither fibrogenic proteins nor miRNA-21 were upregulated; instead, miRNA-21-5p was downregulated along with muscle-specific miRNA-133b and miRNA-206, which have a crucial role in muscle cell homeostasis. These observations suggest that the conversion of laminopathic fibroblasts into a profibrotic phenotype is a determinant of EDMD-associated muscle fibrosis, while miRNA-206-dependent defects of laminopathic myoblasts, including altered regulation of VEGF levels, contribute to muscle cell deterioration. Notably, our study provides a proof-of-principle for the application of gene correction to EDMD1 and EDMD2 and presents EDMD1 isogenic cells that exhibit an almost complete rescue of a disease-specific miRNA signature. These cells can be used as experimental models for studying muscular laminopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, University of Modena and Reggio Emilia, 41121 Modena, Italy.
- Centre for Regenerative Medicine, "Stefano Ferrari" University of Modena and Reggio Emilia, 41121 Modena, Italy.
- CNR Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza", Unit of Bologna, 40136 Bologna, Italy.
- IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
- Neurology 4-Neuroimmunology and Neuromuscular Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.
- Neurology III-Neuroalgology Unit, IRCCS "C. Besta" Neurologic Institute, 20133 Milan, Italy.
ORCID-Profile: Eleonora Cattin, Elisa Schena, Elisabetta Mattioli, Stefania Marcuzzo, Silvia Bonanno, Paola Cavalcante, Federico Corradi, Daniela Benati, Giorgia Farinazzo, Veronica De Sanctis, Roberto Bertorelli, Lorenzo Maggi, Antonella Pini, Gaetano Vattemi, Marco Cavallo, Cristina Manferdini, Gina Lisignoli, Beatrice Fontana, Roberta Roncarati, Manuela Ferracin, Eric C Schirmer, Alessandra Recchia, Giovanna Lattanzi
Förderung
- Ministero dell'università e della ricerca
- Associazione Italiana DIstrofia Muscolare di Emery-Dreifuss - AIDMED
- Associazione Alessandra Proietti OdV
- EU-funded PNRR
- AIFA
- Ministero della Salute
- The Italian Ministry of Health
- AIDMED project CUP
Zitieren
APA
Cattin, E., Schena, E., Mattioli, E., Marcuzzo, S., Bonanno, S., Cavalcante, P., Corradi, F., Benati, D., Farinazzo, G., Cattaneo, M., De Sanctis, V., Bertorelli, R., Maggi, L., Giannotta, M., Pini, A., Vattemi, G., Cassandrini, D., Cavallo, M., Manferdini, C., …, & Lattanzi, G. (2025). Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts. Cells. https://doi.org/10.3390/cells14171321
Vancouver
Cattin E, Schena E, Mattioli E, Marcuzzo S, Bonanno S, Cavalcante P, et al. Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts. Cells. 2025. doi:10.3390/cells14171321
BibTeX
@article{Cattin2025,
author = {Cattin, Eleonora and Schena, Elisa and Mattioli, Elisabetta and Marcuzzo, Stefania and Bonanno, Silvia and Cavalcante, Paola and Corradi, Federico and Benati, Daniela and Farinazzo, Giorgia and Cattaneo, Marco and De Sanctis, Veronica and Bertorelli, Roberto and Maggi, Lorenzo and Giannotta, Melania and Pini, Antonella and Vattemi, Gaetano and Cassandrini, Denise and Cavallo, Marco and Manferdini, Cristina and Lisignoli, Gina and Fontana, Beatrice and Pace, Ilaria and Bruno, Claudio and Roncarati, Roberta and Fiorillo, Chiara and Ferracin, Manuela and Schirmer, Eric C and Recchia, Alessandra and Lattanzi, Giovanna},
title = {Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14171321}
}
EUVIMED